CrossBridge Bio, Inc., a pre-clinical biotechnology company pioneering the development of next-generation dual-payload ...

CrossBridge Bio develops a dual-payload ADC technology created by Kyoji Tsuchikama at the University of Texas Health Science ...

Eli Lilly's acquisition spree shows no sign of stalling, although the Big Pharma is keeping the terms of its latest buy ...

Eli Lilly, the maker of the popular GLP-1 injectable Mounjaro, has invested heavily in Houston as a biotechnology hub.

Eli Lilly (LLY) stock is in focus as the company agrees to acquire CrossBridge Bio, a cancer-focused biotech startup, for up ...

Innovative biotechnology company CrossBridge Bio to be acquired by US pharmaceutical major Eli Lilly in up to USD 300 million ...

Preview this article 1 min CrossBridge Bio is developing unique methods to transport chemotherapy to cancer cells, and its ...

Deal highlights growing demand for advanced targeted cancer treatment technologies Sharjah: CE-Ventures, the corporate ...

CrossBridge Bio, a biotechnology company developing next-generation antibody-drug conjugates based on discoveries by ...

Texan pre-clinical stage biotech CrossBridge Bio, a developer of dual-payload antibody-drug conjugates (ADCs), has announced ...

CE-Ventures, the corporate venture capital arm of the UAE-based investment firm Crescent Enterprises, has announced that its ...

Eli Lilly has agreed to pay up to $300 million for pre-clinical biotechnology company CrossBridge Bio in a deal that bolsters the drugmaker's cancer pipeline. The purchase price includes an ...